Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 584,177 | 690,648 | 491,041 | 578,929 | 661,497 |
| Marketable Securities | 335,901 | 369,432 | N/A | N/A | N/A |
| Receivables | 94,962 | 32,105 | 21,380 | 297,240 | 123,657 |
| Inventories | 8,638 | 9,172 | 15,778 | 41,696 | 69,592 |
| TOTAL | $1,103,680 | $1,203,370 | $727,120 | $1,143,888 | $1,006,764 |
| Non-Current Assets | |||||
| PPE Net | 285,724 | 288,559 | 291,093 | 305,771 | 300,982 |
| Intangibles | 126,766 | 123,377 | 123,179 | 127,454 | 123,780 |
| Other Non-Current Assets | 196,313 | 203,340 | 212,142 | 220,377 | 225,631 |
| TOTAL | $608,803 | $615,276 | $626,414 | $653,602 | $650,393 |
| Total Assets | $1,712,483 | $1,818,646 | $1,353,534 | $1,797,490 | $1,657,157 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 57,517 | 79,962 | 57,724 | 132,610 | 101,914 |
| Accrued Expenses | 218,674 | 159,221 | 257,365 | 394,668 | 311,201 |
| Other current liabilities | 281,715 | 242,811 | 242,102 | 861,408 | 861,956 |
| TOTAL | $1,180,999 | $1,157,811 | $804,382 | $1,635,138 | $1,468,590 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 613,418 | 666,390 | 240,900 | 241,310 | 192,187 |
| Other Non-Current Liabilities | 488,182 | 504,140 | 520,154 | 201,146 | 204,917 |
| TOTAL | $1,057,920 | $1,092,541 | $1,416,236 | $879,279 | $866,917 |
| Total Liabilities | $2,238,919 | $2,250,352 | $2,220,618 | $2,514,417 | $2,335,507 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,185 | 160,094 | 140,404 | 139,953 | 118,790 |
| Common Shares | 1,616 | 1,613 | 1,417 | 1,405 | 1,196 |
| Retained earnings | -4,927,420 | -4,806,120 | -4,968,501 | -4,820,951 | -4,642,562 |
| Other shareholders' equity | 3,738 | -10,947 | -10,775 | 2,455 | -11,569 |
| TOTAL | $-526,436 | $-431,706 | $-867,084 | $-716,927 | $-678,350 |
| Total Liabilities And Equity | $1,712,483 | $1,818,646 | $1,353,534 | $1,797,490 | $1,657,157 |